These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15164159)
21. The antidepressant, nefazodone, attenuates corticosterone-induced increases in 5-HT2A receptor-mediated behaviors in the female rat. Hanson LA; Gorzalka BB; Brotto LA Eur J Pharmacol; 1998 Jan; 342(2-3):163-5. PubMed ID: 9548381 [TBL] [Abstract][Full Text] [Related]
22. Nefazodone: preclinical pharmacology of a new antidepressant. Eison AS; Eison MS; Torrente JR; Wright RN; Yocca FD Psychopharmacol Bull; 1990; 26(3):311-5. PubMed ID: 2274630 [TBL] [Abstract][Full Text] [Related]
23. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972 [TBL] [Abstract][Full Text] [Related]
24. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970 [TBL] [Abstract][Full Text] [Related]
25. Opposite effects of nefazodone in two human models of anxiety. Silva M; Hetem LA; GuimarĂ£es FS; Graeff FG Psychopharmacology (Berl); 2001 Aug; 156(4):454-60. PubMed ID: 11498723 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of alprazolam on the enhancement of lung metastases induced by operative stress in rats. Freiregarabal M; Nuneziglesias M; Balboa J; Fernandezrial J; Garciavallejo L; Gonzalezpatino E; Reymendez M Int J Oncol; 1993 Sep; 3(3):513-7. PubMed ID: 21573393 [TBL] [Abstract][Full Text] [Related]
27. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer. Stutman O Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934 [TBL] [Abstract][Full Text] [Related]
29. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840 [TBL] [Abstract][Full Text] [Related]
30. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic dose range of nefazodone in the treatment of major depression. Robinson DS; Marcus RN; Archibald DG; Hardy SA J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365 [TBL] [Abstract][Full Text] [Related]
32. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. Shen J; Kennedy SH; Levitan RD; Kayumov L; Shapiro CM J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992 [TBL] [Abstract][Full Text] [Related]
33. Stimulatory effects of amphetamine on the development of Walker-256 carcinoma lung metastases in rats. Freiregarabal M; Nuneziglesias M; Losada C; Pereiroraposo M; Castrobolano C; Heras J; Riveiro P; Mayan J; Reymendez M Oncol Rep; 1996 Jan; 3(1):201-4. PubMed ID: 21594344 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes. Lee S; Lee HA; Choi SW; Kim SJ; Kim KS Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276 [TBL] [Abstract][Full Text] [Related]
35. The effect of nefazodone on clozapine plasma concentrations. Taylor D; Bodani M; Hubbeling A; Murray R Int Clin Psychopharmacol; 1999 May; 14(3):185-7. PubMed ID: 10435773 [TBL] [Abstract][Full Text] [Related]
36. 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment. Mongeau R; Martin CB; Chevarin C; Maldonado R; Hamon M; Robledo P; Lanfumey L J Neurochem; 2010 Oct; 115(2):438-49. PubMed ID: 20796171 [TBL] [Abstract][Full Text] [Related]
37. Nefazodone: aspects of efficacy. Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973 [TBL] [Abstract][Full Text] [Related]
38. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity. Sajatovic M; DiGiovanni S; Fuller M; Belton J; DeVega E; Marqua S; Liebling D Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738 [TBL] [Abstract][Full Text] [Related]
39. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression. Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868 [TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Peng M; Ball-Kell SM; Tyner AL Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]